Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo

References

• ThompsonWWShayDKWeintraubEMortality associated with influenza and respiratory syncytial virus in the United StatesJAMA2003289217918612517228
   PubMed Web of Science ®Google Scholar
• DushoffJPlotkinJBViboudCEarnDJSimonsenLMortality due to influenza in the United States–an annualized regression approach using multiple-cause mortality dataAm J Epidemiol2006163218118710.1093/aje/kwj02416319291
   PubMed Web of Science ®Google Scholar
• FraserCDonnellyCACauchemezSPandemic potential of a strain of influenza A (H1N1): early findingsScience200932459341557156110.1126/science.117606219433588
   PubMed Web of Science ®Google Scholar
• DobrovolnyHMBeaucheminCAAModelling the emergence of influenza drug resistance: the roles of surface proteins, the immune response and antiviral mechanismsPLoS One2017127e018058210.1371/journal.pone.018058228700622
   PubMed Web of Science ®Google Scholar
• NicholsonKGAokiFYOsterhausADEfficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase inhibitor flu treatment investigator groupLancet200035592181845185010866439
   PubMed Web of Science ®Google Scholar
• AokiFYMacleodMDPaggiaroPEarly administration of oral oseltamivir increases the benefits of influenza treatmentJ Antimicrob Chemother200351112312912493796
   PubMed Web of Science ®Google Scholar
• LiZWatanabeTHattaMMutational analysis of conserved amino acids in the influenza A virus nucleoproteinJ Virol20098394153416210.1128/JVI.02642-0819225007
   PubMed Web of Science ®Google Scholar
• ElbashirSMHarborthJLendeckelWYalcinAWeberKTuschlTDuplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature2001411683649449810.1038/3507810711373684
   PubMed Web of Science ®Google Scholar
• HammondSMBernsteinEBeachDHannonGJAn RNA-directed nuclease mediates post-transcriptional gene silencing in drosophila cellsNature2000404677529329610.1038/3500510710749213
   PubMed Web of Science ®Google Scholar
• NishikuraKA short primer on RNAi: RNA-directed RNA polymerase acts as a key catalystCell2001107441541811719182
   PubMed Web of Science ®Google Scholar
• SongYFengYLeblancMHCastagloniNJrLiuYM1-Benzyl-1,2,3,4-tetrahydroisoquinoline passes through the blood-brain barrier of rat brain: an in vivo microdialysis studyNeurosci Lett20063951636610.1016/j.neulet.2005.10.05016289318
   PubMed Web of Science ®Google Scholar
• GeQFilipLBaiANguyenTEisenHNChenJInhibition of influenza virus production in virus-infected mice by RNA interferenceProc Natl Acad Sci U S A2004101238676868110.1073/pnas.040248610115173599
   PubMed Web of Science ®Google Scholar
• RajputRKhannaMKumarPSmall interfering RNA targeting the nonstructural gene 1 transcript inhibits influenza A virus replication in experimental miceNucleic Acid Ther201222641442210.1089/nat.2012.035923062009
   PubMed Web of Science ®Google Scholar
• LinLLiuQBerubeNDetmerSZhouY5′-Triphosphate-short interfering RNA: potent inhibition of influenza A virus infection by gene silencing and RIG-I activationJ Virol20128619103591036910.1128/JVI.00665-1222787226
   PubMed Web of Science ®Google Scholar
• DerossiDChassaingGProchiantzATrojan peptides: the penetratin system for intracellular deliveryTrends Cell Biol19988284879695814
   PubMed Web of Science ®Google Scholar
• Sanchez-NavarroMTeixidoMGiraltEJumping hurdles: peptides able to overcome biological barriersAcc Chem Res2017501847185410.1021/acs.accounts.7b0020428715199
   PubMed Web of Science ®Google Scholar
• SubramanyaSKimSSAbrahamSTargeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine productionJ Virol20108452490250110.1128/JVI.02105-0820015996
   PubMed Web of Science ®Google Scholar
• SubramanyaSArmantMSalkowitzJREnhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNAMol Ther201018112028203710.1038/mt.2010.14820648001
   PubMed Web of Science ®Google Scholar
• Barany-WalljeEGaurJLundbergPLangelUGraslundADifferential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargoFEBS Lett2007581132389239310.1016/j.febslet.2007.04.04617485081
   PubMed Web of Science ®Google Scholar
• ShuklaRSJainAZhaoZChengKIntracellular trafficking and exocytosis of a multi-component siRNA nanocomplexNanomedicine20161251323133410.1016/j.nano.2016.02.00326970028
   PubMed Web of Science ®Google Scholar
• ZhuPJinLCell penetrating peptides: a promising tool for the cellular uptake of macromolecular drugsCurr Protein Pept Sci201819221122010.2174/138920371866617071011524028699510
   PubMed Web of Science ®Google Scholar
• ParnasteLArukuuskPLangelKTensonTLangelUThe formation of nanoparticles between small interfering RNA and amphipathic cell-penetrating peptidesMol Ther Nucleic Acids2017711010.1016/j.omtn.2017.02.00328624185
   PubMedGoogle Scholar
• ZellerSChoiCSUchilPDAttachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNAChem Biol2015221506210.1016/j.chembiol.2014.11.00925544044
   PubMedGoogle Scholar
• PoogaMHallbrinkMZorkoMLangelUCell penetration by transportanFASEB J199812167779438412
   PubMed Web of Science ®Google Scholar
• WierzbickiPMKogut-WierzbickaMRuczynskiJProtein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell linesFolia Histochem Cytobiol201452427028010.5603/FHC.a2014.003525511292
   PubMed Web of Science ®Google Scholar
• SoometsULindgrenMGalletXDeletion analogues of transportanBiochim Biophys Acta20001467116517610930519
   PubMed Web of Science ®Google Scholar
• AnkoMMajhencJKogejKInfluence of stearyl and trifluo-romethylquinoline modifications of the cell penetrating peptide TP10 on its interaction with a lipid membraneBiochim Biophys Acta20121818391592410.1016/j.bbamem.2011.12.02822240008
   PubMed Web of Science ®Google Scholar
• LiuBRLinMDChiangHJLeeHJArginine-rich cell-penetrating peptides deliver gene into living human cellsGene20125051374510.1016/j.gene.2012.05.05322669044
   PubMed Web of Science ®Google Scholar
• KimSSYeCKumarPTargeted delivery of siRNA to macrophages for anti-inflammatory treatmentMol Ther2010185993100110.1038/mt.2010.2720216529
   PubMed Web of Science ®Google Scholar
• NakaseINoguchiKAokiATakatani-NakaseTFujiiIFutakiSArginine-rich cell-penetrating peptide-modified extracellular vesicles for active macropinocytosis induction and efficient intracellular deliverySci Rep201771199110.1038/s41598-017-02014-628512335
   PubMed Web of Science ®Google Scholar
• YeCChoiJGAbrahamSHuman macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse modelProc Natl Acad Sci U S A201210951210522105710.1073/pnas.121619510923213216
   PubMed Web of Science ®Google Scholar
• JainABarveAZhaoZJinWChengKComparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA deliveryMol Pharm20171451517152710.1021/acs.molpharmaceut.6b0093328026957
   PubMed Web of Science ®Google Scholar
• ZhaoZLiYJainADevelopment of a peptide-modified siRNA nanocomplex for hepatic stellate cellsNanomedicine2018141516110.1016/j.nano.2017.08.01728890106
   PubMed Web of Science ®Google Scholar
• DeshayesSMorrisMHeitzFDivitaGDelivery of proteins and nucleic acids using a non-covalent peptide-based strategyAdv Drug Deliv Rev2008604–553754710.1016/j.addr.2007.09.00518037526
   PubMed Web of Science ®Google Scholar
• MeadeBRDowdySFEnhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptidesAdv Drug Deliv Rev2008604–553053610.1016/j.addr.2007.10.00418155315
   PubMed Web of Science ®Google Scholar
• LvHZhangSWangBCuiSYanJToxicity of cationic lipids and cationic polymers in gene deliveryJ Control Release2006114110010910.1016/j.jconrel.2006.04.01416831482
   PubMed Web of Science ®Google Scholar
• MorilleMPassiraniCVonarbourgAClavreulABenoitJPProgress in developing cationic vectors for non-viral systemic gene therapy against cancerBiomaterials20082924–253477349610.1016/j.biomaterials.2008.04.03618499247
   PubMed Web of Science ®Google Scholar
• WeaverEARubrumAMWebbyRJBarryMAProtection against divergent influenza H1N1 virus by a centralized influenza hemagglutininPLoS One201163e1831410.1371/journal.pone.001831421464940
   PubMed Web of Science ®Google Scholar
• QuilianoMValdivia-OlarteHOlivaresCMolecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virusBioinformation201391367367910.6026/9732063000967323930018
   PubMedGoogle Scholar
• GeQMcManusMTNguyenTRNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcriptionProc Natl Acad Sci U S A200310052718272310.1073/pnas.043784110012594334
   PubMed Web of Science ®Google Scholar
• KumarPWuHMcBrideJLTransvascular delivery of small interfering RNA to the central nervous systemNature20074487149394310.1038/nature0590117572664
   PubMed Web of Science ®Google Scholar
• Collado CampsEBrockRAn opportunistic route to success: towards a change of paradigm to fully exploit the potential of cell-penetrating peptidesBioorg Med Chem201826102780278710.1016/j.bmc.2017.11.00429157727
   PubMed Web of Science ®Google Scholar
• CrombezLMorrisMCDufortSTargeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growthNucleic Acids Res200937144559456910.1093/nar/gkp45119483097
   PubMed Web of Science ®Google Scholar
• KimYWGrossmannTNVerdineGLSynthesis of all-hydrocarbon stapled alpha-helical peptides by ring-closing olefin metathesisNat Protoc20116676177110.1038/nprot.2011.32421637196
   PubMed Web of Science ®Google Scholar
• LehtoTAbesROskolkovNDelivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategyJ Control Release20101411425110.1016/j.jconrel.2009.08.02819744531
   PubMed Web of Science ®Google Scholar
• MajumderPBhuniaSChaudhuriAA lipid-based cell penetrating nano-assembly for RNAi-mediated anti-angiogenic cancer therapyChem Commun (Camb)201854121489149210.1039/c7cc08517f29359766
   PubMed Web of Science ®Google Scholar
• ShangLNienhausKNienhausGUEngineered nanoparticles interacting with cells: size mattersJ Nanobiotechnology201412510.1186/1477-3155-12-524491160
   PubMed Web of Science ®Google Scholar
• MironavaTHadjiargyrouMSimonMJurukovskiVRafailovichMHGold nanoparticles cellular toxicity and recovery: effect of size, concentration and exposure timeNanotoxicology20104112013710.3109/1743539090347146320795906
   PubMed Web of Science ®Google Scholar
• LunovOSyrovetsTLoosCAmino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophagesACS Nano20115129648965710.1021/nn203596e22111911
   PubMed Web of Science ®Google Scholar
• ZhaoYSunXZhangGTrewynBGSlowingIILinVSInteraction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effectsACS Nano2011521366137510.1021/nn103077k21294526
   PubMed Web of Science ®Google Scholar
• TompkinsSMLoCYTumpeyTMEpsteinSLProtection against lethal influenza virus challenge by RNA interference in vivoProc Natl Acad Sci U S A2004101238682868610.1073/pnas.040263010115173583
   PubMed Web of Science ®Google Scholar
• FreireJMRego de FigueiredoIValleJsiRNA-cell-penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as modelJ Control Release201724512713610.1016/j.jconrel.2016.11.02727890856
   PubMed Web of Science ®Google Scholar